Interplay of the HIV-1 Env cytoplasmic tail, Gag-MA, and membrane: resolving molecular detail and blocking assembly
HIV-1 Env 胞质尾部、Gag-MA 和膜的相互作用:解析分子细节并阻断组装
基本信息
- 批准号:10772333
- 负责人:
- 金额:$ 82.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-03 至 2027-07-31
- 项目状态:未结题
- 来源:
- 关键词:Amino Acid SubstitutionAntiviral AgentsBindingBiochemicalBiochemistryBiological AssayCell Membrane PermeabilityCellsChargeCoupledCryo-electron tomographyCyclic PeptidesCytoplasmic TailCytoplasmic matrixDataDrug DesignEpitopesEvaluationGenerationsGoalsGrainHIVHIV envelope proteinHIV-1ImageIn VitroLengthLifeLipidsLyticMechanicsMembraneMembrane LipidsModelingMolecularMolecular CloningMutationNaturePeptidesPhosphatidylinositol 4,5-DiphosphatePositioning AttributeProductionProtein EngineeringRecombinantsReportingResolutionRoleStructureTestingTimeTransmembrane DomainVariantViralViral PhysiologyVirionVirusWorkcell typecostdensitydesignenv Gene Productsfitnessflexibilityin silicoin situ imaginginhibitorinnovationinsightmolecular dynamicsmulti-scale modelingmultidisciplinarynovelnovel therapeuticsparticlesimulationsynergismtransmission processvirology
项目摘要
PROJECT SUMMARY/ABSTRACT
The goal of this innovative project is to bring together multidisciplinary expertise to dissect the functional,
structural, and dynamic nature of interactions between the HIV-1 envelope (Env) cytoplasmic tail (CT), the
underlying Gag matrix (MA) lattice, and the lipid containing membrane in the context of native virions. We will
utilize state-of-the-art cryo-electron tomography (cryo-ET), molecular dynamics (MD) simulations, modeling, and
in vitro studies to produce a comprehensive rendition of how interactions between these key determinants of
assembly and infectivity are orchestrated. Our studies are based on recent cryo-ET data in which the positioning
of Env CT and MA interactions differed from previous models. In Aim 1, we will harness the power of cryo-ET to
advance the resolution of Env CT-MA interactions to facilitate further interrogation of the mechanics of Env CT-
MA-membrane interactions. In Aim 2, we will generate atomistic models of Env CT-MA in the context of the viral
membrane using high resolution structures and cryo-ET density, and strategic mutations and truncations of Env
CT and MA. In Aim 3, we will exploit conserved structural features to design novel antiviral agents comprised of
membrane-permeable cyclic peptide inhibitors. These Aims are supported by comprehensive biochemical and
virologic approaches and will use a well characterized clade C transmitted/founder (T/F) HIV-1 infectious
molecular clone that is fully representative of global isolates and presents fully matched Env and Gag
components, which distinguishes our work. Our studies will reveal in unprecedented detail how Env CT, MA, and
membrane lipids engage one another, with all components in near native context. These powerful approaches
will produce an integrated model, including flexible regions that are difficult to resolve, to bring the complete Env-
MA-membrane machinery to life.
项目总结/摘要
这个创新项目的目标是汇集多学科的专业知识,剖析功能,
HIV-1包膜(Env)胞质尾区(CT),
潜在的Gag基质(MA)晶格,以及天然病毒体背景下的含脂质膜。我们将
利用最先进的低温电子断层扫描(cryo-ET)、分子动力学(MD)模拟、建模和
体外研究,以全面再现这些关键决定因素之间的相互作用,
组装和传染性是精心安排的。我们的研究是基于最近的低温ET数据,其中定位
Env CT和MA相互作用的结果与以前的模型不同。在目标1中,我们将利用低温ET的力量,
推进Env CT-MA相互作用的解决方案,以促进进一步询问Env CT的机制-
MA-膜相互作用。在目标2中,我们将在病毒的背景下生成Env CT-MA的原子模型。
使用高分辨率结构和冷冻ET密度,以及Env的战略突变和截短,
CT和MA。在目标3中,我们将利用保守的结构特征来设计新的抗病毒药物,
膜渗透性环肽抑制剂。这些目标得到了全面的生物化学和
病毒学方法,并将使用充分表征的C型传播/创始者(T/F)HIV-1感染性
完全代表全球分离株并呈现完全匹配的Env和Gag的分子克隆
这是我们工作的一个特点。我们的研究将以前所未有的细节揭示Env CT、MA和
膜脂彼此接合,所有组分都接近天然环境。这些强大的方法
将产生一个综合模型,包括难以解决的灵活区域,使完整的环境,
MA-膜机械的生命。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Cynthia Ann Derdeyn其他文献
Cynthia Ann Derdeyn的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Cynthia Ann Derdeyn', 18)}}的其他基金
Tracking the evolutionary trajectory of neutralizing antibodies following BG505 SOSIP immunization
追踪 BG505 SOSIP 免疫后中和抗体的进化轨迹
- 批准号:
10620979 - 财政年份:2023
- 资助金额:
$ 82.76万 - 项目类别:
Novel treatment for respiratory distress due to SARS-CoV2 infection
治疗 SARS-CoV2 感染引起的呼吸窘迫的新疗法
- 批准号:
10284733 - 财政年份:2021
- 资助金额:
$ 82.76万 - 项目类别:
Novel treatment for respiratory distress due to SARS-CoV2 infection
治疗 SARS-CoV2 感染引起的呼吸窘迫的新疗法
- 批准号:
10426353 - 财政年份:2021
- 资助金额:
$ 82.76万 - 项目类别:
Discovery of Novel Epitopes for Antibody Dependent Cell-mediated Cytotoxicity Against HIV-1 Infected Cells
发现抗体依赖性细胞介导的针对 HIV-1 感染细胞的细胞毒性的新表位
- 批准号:
10031027 - 财政年份:2020
- 资助金额:
$ 82.76万 - 项目类别:
Discovery of Novel Epitopes for Antibody Dependent Cell-mediated Cytotoxicity Against HIV-1 Infected Cells
发现抗体依赖性细胞介导的针对 HIV-1 感染细胞的细胞毒性的新表位
- 批准号:
10113530 - 财政年份:2020
- 资助金额:
$ 82.76万 - 项目类别:
NOVEL EPITOPES THAT MEDIATE BROAD NEUTRALIZATION OF CLADE B AND C HIV-1 ISOLATES
介导 B 型和 C 型 HIV-1 分离株广泛中和的新表位
- 批准号:
8357473 - 财政年份:2011
- 资助金额:
$ 82.76万 - 项目类别:
ANTIBODY NEUTRALIZATION AND ESCAPE IN SUBTYPE C HIV-1
C 亚型 HIV-1 中的抗体中和和逃逸
- 批准号:
8357423 - 财政年份:2011
- 资助金额:
$ 82.76万 - 项目类别:
NOVEL EPITOPES THAT MEDIATE BROAD NEUTRALIZATION OF CLADE B AND C HIV-1 ISOLATES
介导 B 型和 C 型 HIV-1 分离株广泛中和的新表位
- 批准号:
8172428 - 财政年份:2010
- 资助金额:
$ 82.76万 - 项目类别:
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
$ 82.76万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
$ 82.76万 - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
$ 82.76万 - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
$ 82.76万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
$ 82.76万 - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
$ 82.76万 - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
$ 82.76万 - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 82.76万 - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
$ 82.76万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
$ 82.76万 - 项目类别: